The California-based marijuana big MedMen launched a false statement this week saying it had signed a definitive settlement to accumulate a licensed dispensary from Berkeley Patients Group, one of many nation’s oldest marijuana retailers.
After the statement was reported by information retailers and shared on social media, Étienne Fontán, the director of Berkeley Patients Group (BPG), wrote on Facebook that the Bay Area retailer was “blindsided” by MedMen’s “misleading” launch.
MedMen corrected the discharge Thursday to make clear it had the truth is acquired the license from B12, a restricted legal responsibility firm owned by 5 people, of whom two are principals at Berkeley Patients Group.
“Because of the overlap of players between B12 and (Berkeley Patients Group) and the contacts we were in conversations with during negotiations, we inadvertently used BPG when we should have used B12 as the party in the release,” wrote Daniel Yi, MedMen’s senior vice chairman of company communications, in an e mail to Marijuana Business Daily. “It was accidental, not intentional.”
The inaccurate launch prompted Berkeley Patients Group to make clear by way of Twitter that the 19-year-old dispensary is by no means affiliated with MedMen, had not been bought and isn’t on the market.